首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >Changes in 20S subunit composition are largely responsible for altered proteasomal activities in experimental autoimmune encephalomyelitis.
【24h】

Changes in 20S subunit composition are largely responsible for altered proteasomal activities in experimental autoimmune encephalomyelitis.

机译:在实验性自身免疫性脑脊髓炎中,蛋白酶体活性的改变在很大程度上与20S亚基组成的改变有关。

获取原文
获取原文并翻译 | 示例
           

摘要

We recently reported that the proteasomal peptidase activities are altered in the cerebellum of mice with myelin oligodendrocyte glycoprotein (MOG) peptide-induced experimental autoimmune encephalomyelitis (EAE). To determine whether these fluctuations are caused by proteasome activation/inactivation and/or changes in the levels of individual β subunits, we characterized the proteasome subunit composition by western blotting. The results show that the rise in proteasomal peptidase activity in acute EAE correlates with an augmented expression of inducible β subunits whereas the decline in activity in chronic EAE correlates with a reduction in the amount of standard β subunits. Using pure standard (s) and immuno (i) 20S particles for calibration, we determined that the changes in the levels of catalytic subunits account for all of the fluctuations in peptidase activities in EAE. The i-20S and s-20S proteasome were found to degrade carbonylated β-actin with similar efficiency, suggesting that the amount of protein carbonyls in EAE may be controlled by the activity of both core particles. We also found an increase in proteasome activator 11S regulatory particle and a decrease in inhibitor proteasome inhibitor with molecular mass of 31 kDa levels in acute EAE, reflecting a response to inflammation. Elevated levels of 19S regulatory particle and 11S regulatory particle in chronic EAE, however, may occur in response to diminished proteasomal activity in this phase. These findings are central towards understanding the altered proteasomal physiology in inflammatory demyelinating disorders.
机译:我们最近报道,在髓鞘少突胶质细胞糖蛋白(MOG)肽诱导的实验性自身免疫性脑脊髓炎(EAE)的小鼠小脑中,蛋白酶体肽酶活性发生了改变。为了确定这些波动是否是由蛋白酶体的活化/失活和/或单个β亚基水平的变化引起的,我们通过蛋白质印迹法对蛋白酶体亚基的组成进行了表征。结果表明,急性EAE中蛋白酶体肽酶活性的升高与诱导型β亚基表达的增加有关,而慢性EAE中活性的下降与标准β亚基的减少有关。使用纯标准品和免疫性(i)20S颗粒进行校准,我们确定催化亚基水平的变化解释了EAE中肽酶活性的所有波动。发现i-20S和s-20S蛋白酶体以相似的效率降解羰基化的β-肌动蛋白,这表明EAE中蛋白质羰基的数量可能受两个核心颗粒的活性控制。我们还发现在急性EAE中,蛋白酶体激活剂11S调节颗粒的增加和抑制剂蛋白酶体抑制剂的减少(分子量为31 kDa)反映了对炎症的反应。然而,在此阶段中,由于蛋白酶体活性降低,可能会导致慢性EAE中19S调节颗粒和11S调节颗粒的水平升高。这些发现对于了解炎症性脱髓鞘疾病中蛋白酶体生理学的改变至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号